SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 186.85-0.8%1:10 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (16955)3/9/1998 5:04:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
Thanks for the stats. Speaking of hard data, on March 4 Cowan came out with a list of upcoming clinical conferences.
I'm not sure how accurate the list is, but they show four upcoming conferences for LGND.

The first is AACR (American Association for Cancer Research) which meets form March 28 - April 1. LGND is supposed to talk about retinoid compounds for multiple cancers.

Next is ASCO (American Society for Clinical Oncology) meeting from May 16-19. LGND is slated for Oral Panretin treatment of Kaposi's Sarcoma

The Diabetes Association is then having a conference from June 13-16. It's slated to be a LLY/LGND presentation on Targretin Analogs for treating Type II Diabetes.

The fourth conference is the International AIDS Conference from June 28-July 3. LGND will be presenting on treating KS with Panretin gel and capsules.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext